A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test

As of October 2020, there is still no specific drug to treat COVID-19 as it rages worldwide. Favipiravir, indicated for the treatment of new and re-emerging influenza infections, has been suggested to be effective against SARS-CoV-2, although this is not yet fully validated. We administered favipira...

Descripción completa

Detalles Bibliográficos
Autores principales: Murai, Yushi, Kawasuji, Hitoshi, Takegoshi, Yusuke, Kaneda, Makito, Kimoto, Kou, Ueno, Akitoshi, Miyajima, Yuki, Kawago, Koyomi, Fukui, Yasutaka, Ogami, Chika, Sakamaki, Ippei, Tsuji, Yasuhiro, Morinaga, Yoshitomo, Yamamoto, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970795/
https://www.ncbi.nlm.nih.gov/pubmed/33746092
http://dx.doi.org/10.1016/j.ijid.2021.03.048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970795/
https://www.ncbi.nlm.nih.gov/pubmed/33746092
http://dx.doi.org/10.1016/j.ijid.2021.03.048

Ejemplares similares